1 Market Overview

1.1 Product Overview and Scope of Migraine Therapeutics

1.2 Classification of Migraine Therapeutics by Type

1.2.1 Overview: Global Migraine Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Migraine Therapeutics Revenue Market Share by Type in 2020

1.2.3 Specific Anti-migraine Drugs

1.2.4 Acute Therapies

1.2.5 Preventative Therapies

1.2.6 Other

1.3 Global Migraine Therapeutics Market by Application

1.3.1 Overview: Global Migraine Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Household Use

1.3.5 Others

1.4 Global Migraine Therapeutics Market Size & Forecast

1.5 Global Migraine Therapeutics Market Size and Forecast by Region

1.5.1 Global Migraine Therapeutics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Migraine Therapeutics Market Size by Region, (2016-2021)

1.5.3 North America Migraine Therapeutics Market Size and Prospect (2016-2026)

1.5.4 Europe Migraine Therapeutics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Migraine Therapeutics Market Size and Prospect (2016-2026)

1.5.6 South America Migraine Therapeutics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Migraine Therapeutics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Migraine Therapeutics Market Drivers

1.6.2 Migraine Therapeutics Market Restraints

1.6.3 Migraine Therapeutics Trends Analysis

2 Company Profiles

2.1 Allergan

2.1.1 Allergan Details

2.1.2 Allergan Major Business

2.1.3 Allergan Migraine Therapeutics Product and Solutions

2.1.4 Allergan Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Allergan Recent Developments and Future Plans

2.2 Merck

2.2.1 Merck Details

2.2.2 Merck Major Business

2.2.3 Merck Migraine Therapeutics Product and Solutions

2.2.4 Merck Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Merck Recent Developments and Future Plans

2.3 Pfizer

2.3.1 Pfizer Details

2.3.2 Pfizer Major Business

2.3.3 Pfizer Migraine Therapeutics Product and Solutions

2.3.4 Pfizer Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Pfizer Recent Developments and Future Plans

2.4 Teva

2.4.1 Teva Details

2.4.2 Teva Major Business

2.4.3 Teva Migraine Therapeutics Product and Solutions

2.4.4 Teva Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Teva Recent Developments and Future Plans

2.5 Amgen

2.5.1 Amgen Details

2.5.2 Amgen Major Business

2.5.3 Amgen Migraine Therapeutics Product and Solutions

2.5.4 Amgen Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Amgen Recent Developments and Future Plans

2.6 Johnson & Johnson

2.6.1 Johnson & Johnson Details

2.6.2 Johnson & Johnson Major Business

2.6.3 Johnson & Johnson Migraine Therapeutics Product and Solutions

2.6.4 Johnson & Johnson Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Johnson & Johnson Recent Developments and Future Plans

2.7 Endo International

2.7.1 Endo International Details

2.7.2 Endo International Major Business

2.7.3 Endo International Migraine Therapeutics Product and Solutions

2.7.4 Endo International Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Endo International Recent Developments and Future Plans

2.8 GlaxoSmithKline

2.8.1 GlaxoSmithKline Details

2.8.2 GlaxoSmithKline Major Business

2.8.3 GlaxoSmithKline Migraine Therapeutics Product and Solutions

2.8.4 GlaxoSmithKline Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 GlaxoSmithKline Recent Developments and Future Plans

2.9 Impax

2.9.1 Impax Details

2.9.2 Impax Major Business

2.9.3 Impax Migraine Therapeutics Product and Solutions

2.9.4 Impax Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Impax Recent Developments and Future Plans

2.10 Abbott

2.10.1 Abbott Details

2.10.2 Abbott Major Business

2.10.3 Abbott Migraine Therapeutics Product and Solutions

2.10.4 Abbott Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Abbott Recent Developments and Future Plans

2.11 Bayer

2.11.1 Bayer Details

2.11.2 Bayer Major Business

2.11.3 Bayer Migraine Therapeutics Product and Solutions

2.11.4 Bayer Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Bayer Recent Developments and Future Plans

2.12 Eli Lilly

2.12.1 Eli Lilly Details

2.12.2 Eli Lilly Major Business

2.12.3 Eli Lilly Migraine Therapeutics Product and Solutions

2.12.4 Eli Lilly Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Eli Lilly Recent Developments and Future Plans

2.13 Novartis International

2.13.1 Novartis International Details

2.13.2 Novartis International Major Business

2.13.3 Novartis International Migraine Therapeutics Product and Solutions

2.13.4 Novartis International Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Novartis International Recent Developments and Future Plans

2.14 Ethypharm

2.14.1 Ethypharm Details

2.14.2 Ethypharm Major Business

2.14.3 Ethypharm Migraine Therapeutics Product and Solutions

2.14.4 Ethypharm Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Ethypharm Recent Developments and Future Plans

2.15 Kowa Pharmaceuticals America

2.15.1 Kowa Pharmaceuticals America Details

2.15.2 Kowa Pharmaceuticals America Major Business

2.15.3 Kowa Pharmaceuticals America Migraine Therapeutics Product and Solutions

2.15.4 Kowa Pharmaceuticals America Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Kowa Pharmaceuticals America Recent Developments and Future Plans

2.16 Winston Pharmaceuticals

2.16.1 Winston Pharmaceuticals Details

2.16.2 Winston Pharmaceuticals Major Business

2.16.3 Winston Pharmaceuticals Migraine Therapeutics Product and Solutions

2.16.4 Winston Pharmaceuticals Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Winston Pharmaceuticals Recent Developments and Future Plans

2.17 AstraZeneca

2.17.1 AstraZeneca Details

2.17.2 AstraZeneca Major Business

2.17.3 AstraZeneca Migraine Therapeutics Product and Solutions

2.17.4 AstraZeneca Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 AstraZeneca Recent Developments and Future Plans

2.18 Amirall

2.18.1 Amirall Details

2.18.2 Amirall Major Business

2.18.3 Amirall Migraine Therapeutics Product and Solutions

2.18.4 Amirall Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Amirall Recent Developments and Future Plans

2.19 OptiNose

2.19.1 OptiNose Details

2.19.2 OptiNose Major Business

2.19.3 OptiNose Migraine Therapeutics Product and Solutions

2.19.4 OptiNose Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 OptiNose Recent Developments and Future Plans

2.20 Revance Therapeutics

2.20.1 Revance Therapeutics Details

2.20.2 Revance Therapeutics Major Business

2.20.3 Revance Therapeutics Migraine Therapeutics Product and Solutions

2.20.4 Revance Therapeutics Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Revance Therapeutics Recent Developments and Future Plans

2.21 RedHill Biopharma

2.21.1 RedHill Biopharma Details

2.21.2 RedHill Biopharma Major Business

2.21.3 RedHill Biopharma Migraine Therapeutics Product and Solutions

2.21.4 RedHill Biopharma Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 RedHill Biopharma Recent Developments and Future Plans

2.22 Bausch Health

2.22.1 Bausch Health Details

2.22.2 Bausch Health Major Business

2.22.3 Bausch Health Migraine Therapeutics Product and Solutions

2.22.4 Bausch Health Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Bausch Health Recent Developments and Future Plans

2.23 NeurAxon

2.23.1 NeurAxon Details

2.23.2 NeurAxon Major Business

2.23.3 NeurAxon Migraine Therapeutics Product and Solutions

2.23.4 NeurAxon Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 NeurAxon Recent Developments and Future Plans

2.24 Biohaven Pharma

2.24.1 Biohaven Pharma Details

2.24.2 Biohaven Pharma Major Business

2.24.3 Biohaven Pharma Migraine Therapeutics Product and Solutions

2.24.4 Biohaven Pharma Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.24.5 Biohaven Pharma Recent Developments and Future Plans

2.25 Eisai

2.25.1 Eisai Details

2.25.2 Eisai Major Business

2.25.3 Eisai Migraine Therapeutics Product and Solutions

2.25.4 Eisai Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.25.5 Eisai Recent Developments and Future Plans

2.26 Valeant Pharma

2.26.1 Valeant Pharma Details

2.26.2 Valeant Pharma Major Business

2.26.3 Valeant Pharma Migraine Therapeutics Product and Solutions

2.26.4 Valeant Pharma Migraine Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.26.5 Valeant Pharma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Migraine Therapeutics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Migraine Therapeutics Players Market Share

3.2.2 Top 10 Migraine Therapeutics Players Market Share

3.2.3 Market Competition Trend

3.3 Migraine Therapeutics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Migraine Therapeutics Revenue and Market Share by Type (2016-2021)

4.2 Global Migraine Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Migraine Therapeutics Revenue Market Share by Application (2016-2021)

5.2 Migraine Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Migraine Therapeutics Revenue by Type (2016-2026)

6.2 North America Migraine Therapeutics Revenue by Application (2016-2026)

6.3 North America Migraine Therapeutics Market Size by Country

6.3.1 North America Migraine Therapeutics Revenue by Country (2016-2026)

6.3.2 United States Migraine Therapeutics Market Size and Forecast (2016-2026)

6.3.3 Canada Migraine Therapeutics Market Size and Forecast (2016-2026)

6.3.4 Mexico Migraine Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Migraine Therapeutics Revenue by Type (2016-2026)

7.2 Europe Migraine Therapeutics Revenue by Application (2016-2026)

7.3 Europe Migraine Therapeutics Market Size by Country

7.3.1 Europe Migraine Therapeutics Revenue by Country (2016-2026)

7.3.2 Germany Migraine Therapeutics Market Size and Forecast (2016-2026)

7.3.3 France Migraine Therapeutics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Migraine Therapeutics Market Size and Forecast (2016-2026)

7.3.5 Russia Migraine Therapeutics Market Size and Forecast (2016-2026)

7.3.6 Italy Migraine Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Migraine Therapeutics Revenue by Type (2016-2026)

8.2 Asia-Pacific Migraine Therapeutics Revenue by Application (2016-2026)

8.3 Asia-Pacific Migraine Therapeutics Market Size by Region

8.3.1 Asia-Pacific Migraine Therapeutics Revenue by Region (2016-2026)

8.3.2 China Migraine Therapeutics Market Size and Forecast (2016-2026)

8.3.3 Japan Migraine Therapeutics Market Size and Forecast (2016-2026)

8.3.4 South Korea Migraine Therapeutics Market Size and Forecast (2016-2026)

8.3.5 India Migraine Therapeutics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Migraine Therapeutics Market Size and Forecast (2016-2026)

8.3.7 Australia Migraine Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Migraine Therapeutics Revenue by Type (2016-2026)

9.2 South America Migraine Therapeutics Revenue by Application (2016-2026)

9.3 South America Migraine Therapeutics Market Size by Country

9.3.1 South America Migraine Therapeutics Revenue by Country (2016-2026)

9.3.2 Brazil Migraine Therapeutics Market Size and Forecast (2016-2026)

9.3.3 Argentina Migraine Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Migraine Therapeutics Revenue by Type (2016-2026)

10.2 Middle East & Africa Migraine Therapeutics Revenue by Application (2016-2026)

10.3 Middle East & Africa Migraine Therapeutics Market Size by Country

10.3.1 Middle East & Africa Migraine Therapeutics Revenue by Country (2016-2026)

10.3.2 Turkey Migraine Therapeutics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Migraine Therapeutics Market Size and Forecast (2016-2026)

10.3.4 UAE Migraine Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Migraine Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Migraine Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Migraine Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Migraine Therapeutics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Migraine Therapeutics Revenue Market Share by Region (2021-2026)

Table 6. Allergan Corporate Information, Head Office, and Major Competitors

Table 7. Allergan Major Business

Table 8. Allergan Migraine Therapeutics Product and Solutions

Table 9. Allergan Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Merck Corporate Information, Head Office, and Major Competitors

Table 11. Merck Major Business

Table 12. Merck Migraine Therapeutics Product and Solutions

Table 13. Merck Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Pfizer Corporate Information, Head Office, and Major Competitors

Table 15. Pfizer Major Business

Table 16. Pfizer Migraine Therapeutics Product and Solutions

Table 17. Pfizer Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Teva Corporate Information, Head Office, and Major Competitors

Table 19. Teva Major Business

Table 20. Teva Migraine Therapeutics Product and Solutions

Table 21. Teva Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Amgen Corporate Information, Head Office, and Major Competitors

Table 23. Amgen Major Business

Table 24. Amgen Migraine Therapeutics Product and Solutions

Table 25. Amgen Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 27. Johnson & Johnson Major Business

Table 28. Johnson & Johnson Migraine Therapeutics Product and Solutions

Table 29. Johnson & Johnson Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Endo International Corporate Information, Head Office, and Major Competitors

Table 31. Endo International Major Business

Table 32. Endo International Migraine Therapeutics Product and Solutions

Table 33. Endo International Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 35. GlaxoSmithKline Major Business

Table 36. GlaxoSmithKline Migraine Therapeutics Product and Solutions

Table 37. GlaxoSmithKline Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Impax Corporate Information, Head Office, and Major Competitors

Table 39. Impax Major Business

Table 40. Impax Migraine Therapeutics Product and Solutions

Table 41. Impax Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Abbott Corporate Information, Head Office, and Major Competitors

Table 43. Abbott Major Business

Table 44. Abbott Migraine Therapeutics Product and Solutions

Table 45. Abbott Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Bayer Corporate Information, Head Office, and Major Competitors

Table 47. Bayer Major Business

Table 48. Bayer Migraine Therapeutics Product and Solutions

Table 49. Bayer Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 51. Eli Lilly Major Business

Table 52. Eli Lilly Migraine Therapeutics Product and Solutions

Table 53. Eli Lilly Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Novartis International Corporate Information, Head Office, and Major Competitors

Table 55. Novartis International Major Business

Table 56. Novartis International Migraine Therapeutics Product and Solutions

Table 57. Novartis International Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Ethypharm Corporate Information, Head Office, and Major Competitors

Table 59. Ethypharm Major Business

Table 60. Ethypharm Migraine Therapeutics Product and Solutions

Table 61. Ethypharm Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Kowa Pharmaceuticals America Corporate Information, Head Office, and Major Competitors

Table 63. Kowa Pharmaceuticals America Major Business

Table 64. Kowa Pharmaceuticals America Migraine Therapeutics Product and Solutions

Table 65. Kowa Pharmaceuticals America Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Winston Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 67. Winston Pharmaceuticals Major Business

Table 68. Winston Pharmaceuticals Migraine Therapeutics Product and Solutions

Table 69. Winston Pharmaceuticals Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 71. AstraZeneca Major Business

Table 72. AstraZeneca Migraine Therapeutics Product and Solutions

Table 73. AstraZeneca Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Amirall Corporate Information, Head Office, and Major Competitors

Table 75. Amirall Major Business

Table 76. Amirall Migraine Therapeutics Product and Solutions

Table 77. Amirall Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. OptiNose Corporate Information, Head Office, and Major Competitors

Table 79. OptiNose Major Business

Table 80. OptiNose Migraine Therapeutics Product and Solutions

Table 81. OptiNose Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Revance Therapeutics Corporate Information, Head Office, and Major Competitors

Table 83. Revance Therapeutics Major Business

Table 84. Revance Therapeutics Migraine Therapeutics Product and Solutions

Table 85. Revance Therapeutics Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. RedHill Biopharma Corporate Information, Head Office, and Major Competitors

Table 87. RedHill Biopharma Major Business

Table 88. RedHill Biopharma Migraine Therapeutics Product and Solutions

Table 89. RedHill Biopharma Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Bausch Health Corporate Information, Head Office, and Major Competitors

Table 91. Bausch Health Major Business

Table 92. Bausch Health Migraine Therapeutics Product and Solutions

Table 93. Bausch Health Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. NeurAxon Corporate Information, Head Office, and Major Competitors

Table 95. NeurAxon Major Business

Table 96. NeurAxon Migraine Therapeutics Product and Solutions

Table 97. NeurAxon Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. Biohaven Pharma Corporate Information, Head Office, and Major Competitors

Table 99. Biohaven Pharma Major Business

Table 100. Biohaven Pharma Migraine Therapeutics Product and Solutions

Table 101. Biohaven Pharma Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 102. Eisai Corporate Information, Head Office, and Major Competitors

Table 103. Eisai Major Business

Table 104. Eisai Migraine Therapeutics Product and Solutions

Table 105. Eisai Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 106. Valeant Pharma Corporate Information, Head Office, and Major Competitors

Table 107. Valeant Pharma Major Business

Table 108. Valeant Pharma Migraine Therapeutics Product and Solutions

Table 109. Valeant Pharma Migraine Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 110. Global Migraine Therapeutics Revenue (USD Million) by Players (2019-2021)

Table 111. Global Migraine Therapeutics Revenue Share by Players (2019-2021)

Table 112. Breakdown of Migraine Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 113. Migraine Therapeutics Players Head Office, Products and Services Provided

Table 114. Migraine Therapeutics Mergers & Acquisitions in the Past Five Years

Table 115. Migraine Therapeutics New Entrants and Expansion Plans

Table 116. Global Migraine Therapeutics Revenue (USD Million) by Type (2016-2021)

Table 117. Global Migraine Therapeutics Revenue Share by Type (2016-2021)

Table 118. Global Migraine Therapeutics Revenue Forecast by Type (2021-2026)

Table 119. Global Migraine Therapeutics Revenue by Application (2016-2021)

Table 120. Global Migraine Therapeutics Revenue Forecast by Application (2021-2026)

Table 121. North America Migraine Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 122. North America Migraine Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 123. North America Migraine Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 124. North America Migraine Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 125. North America Migraine Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 126. North America Migraine Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 127. Europe Migraine Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 128. Europe Migraine Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 129. Europe Migraine Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 130. Europe Migraine Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 131. Europe Migraine Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 132. Europe Migraine Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 133. Asia-Pacific Migraine Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 134. Asia-Pacific Migraine Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 135. Asia-Pacific Migraine Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 136. Asia-Pacific Migraine Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 137. Asia-Pacific Migraine Therapeutics Revenue by Region (2016-2021) & (USD Million)

Table 138. Asia-Pacific Migraine Therapeutics Revenue by Region (2021-2026) & (USD Million)

Table 139. South America Migraine Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 140. South America Migraine Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 141. South America Migraine Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 142. South America Migraine Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 143. South America Migraine Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 144. South America Migraine Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 145. Middle East & Africa Migraine Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 146. Middle East & Africa Migraine Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 147. Middle East & Africa Migraine Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 148. Middle East & Africa Migraine Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 149. Middle East & Africa Migraine Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 150. Middle East & Africa Migraine Therapeutics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Migraine Therapeutics Picture

Figure 2. Global Migraine Therapeutics Revenue Market Share by Type in 2020

Figure 3. Specific Anti-migraine Drugs

Figure 4. Acute Therapies

Figure 5. Preventative Therapies

Figure 6. Other

Figure 7. Migraine Therapeutics Revenue Market Share by Application in 2020

Figure 8. Hospitals Picture

Figure 9. Clinics Picture

Figure 10. Household Use Picture

Figure 11. Others Picture

Figure 12. Global Migraine Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Migraine Therapeutics Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Migraine Therapeutics Revenue Market Share by Region (2016-2026)

Figure 15. Global Migraine Therapeutics Revenue Market Share by Region in 2020

Figure 16. North America Migraine Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Migraine Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Migraine Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Migraine Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Migraine Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Migraine Therapeutics Market Drivers

Figure 22. Migraine Therapeutics Market Restraints

Figure 23. Migraine Therapeutics Market Trends

Figure 24. Allergan Recent Developments and Future Plans

Figure 25. Merck Recent Developments and Future Plans

Figure 26. Pfizer Recent Developments and Future Plans

Figure 27. Teva Recent Developments and Future Plans

Figure 28. Amgen Recent Developments and Future Plans

Figure 29. Johnson & Johnson Recent Developments and Future Plans

Figure 30. Endo International Recent Developments and Future Plans

Figure 31. GlaxoSmithKline Recent Developments and Future Plans

Figure 32. Impax Recent Developments and Future Plans

Figure 33. Abbott Recent Developments and Future Plans

Figure 34. Bayer Recent Developments and Future Plans

Figure 35. Eli Lilly Recent Developments and Future Plans

Figure 36. Novartis International Recent Developments and Future Plans

Figure 37. Ethypharm Recent Developments and Future Plans

Figure 38. Kowa Pharmaceuticals America Recent Developments and Future Plans

Figure 39. Winston Pharmaceuticals Recent Developments and Future Plans

Figure 40. AstraZeneca Recent Developments and Future Plans

Figure 41. Amirall Recent Developments and Future Plans

Figure 42. OptiNose Recent Developments and Future Plans

Figure 43. Revance Therapeutics Recent Developments and Future Plans

Figure 44. RedHill Biopharma Recent Developments and Future Plans

Figure 45. Bausch Health Recent Developments and Future Plans

Figure 46. NeurAxon Recent Developments and Future Plans

Figure 47. Biohaven Pharma Recent Developments and Future Plans

Figure 48. Eisai Recent Developments and Future Plans

Figure 49. Valeant Pharma Recent Developments and Future Plans

Figure 50. Global Migraine Therapeutics Revenue Share by Players in 2020

Figure 51. Migraine Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 52. Global Top 3 Players Migraine Therapeutics Revenue Market Share in 2020

Figure 53. Global Top 10 Players Migraine Therapeutics Revenue Market Share in 2020

Figure 54. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 55. Global Migraine Therapeutics Revenue Share by Type in 2020

Figure 56. Global Migraine Therapeutics Market Share Forecast by Type (2021-2026)

Figure 57. Global Migraine Therapeutics Revenue Share by Application in 2020

Figure 58. Global Migraine Therapeutics Market Share Forecast by Application (2021-2026)

Figure 59. North America Migraine Therapeutics Sales Market Share by Type (2016-2026)

Figure 60. North America Migraine Therapeutics Sales Market Share by Application (2016-2026)

Figure 61. North America Migraine Therapeutics Revenue Market Share by Country (2016-2026)

Figure 62. United States Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Canada Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Mexico Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Europe Migraine Therapeutics Sales Market Share by Type (2016-2026)

Figure 66. Europe Migraine Therapeutics Sales Market Share by Application (2016-2026)

Figure 67. Europe Migraine Therapeutics Revenue Market Share by Country (2016-2026)

Figure 68. Germany Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. France Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. United Kingdom Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Russia Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Italy Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Asia-Pacific Migraine Therapeutics Sales Market Share by Type (2016-2026)

Figure 74. Asia-Pacific Migraine Therapeutics Sales Market Share by Application (2016-2026)

Figure 75. Asia-Pacific Migraine Therapeutics Revenue Market Share by Region (2016-2026)

Figure 76. China Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Japan Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. South Korea Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. India Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Southeast Asia Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Australia Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. South America Migraine Therapeutics Sales Market Share by Type (2016-2026)

Figure 83. South America Migraine Therapeutics Sales Market Share by Application (2016-2026)

Figure 84. South America Migraine Therapeutics Revenue Market Share by Country (2016-2026)

Figure 85. Brazil Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Argentina Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Middle East and Africa Migraine Therapeutics Sales Market Share by Type (2016-2026)

Figure 88. Middle East and Africa Migraine Therapeutics Sales Market Share by Application (2016-2026)

Figure 89. Middle East and Africa Migraine Therapeutics Revenue Market Share by Country (2016-2026)

Figure 90. Turkey Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 91. Saudi Arabia Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 92. UAE Migraine Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 93. Methodology

Figure 94. Research Process and Data Source